Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
AbstractNon-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease but the second cause of death among NAFLD patients are attributed to malignancies at both gastrointestinal (liver, colon, esophagus, stomach, and pancreas) and extra-intestinal sites (kidney in men, and breast in women). Obesity and related metabolic abnormalities are associated with increased incidence or mortality for a number of cancers. NAFLD has an intertwined relationship with metabolic syndrome and significantly contributes to the risk of hepatocellular carcinoma (HCC), but recent evidence have fuelled concerns that NAFLD may be a new, and added, risk factor for extra-hepatic cancers, particularly in the gastrointestinal tract. In this review we critically appraise key studies on NAFLD-associated extra-hepatic cancers and speculate on how NAFLD may influence carcinogenesis at these sites. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Sanna, C.; Rosso, C.; Marietti, M.; Bugianesi, E. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. Int. J. Mol. Sci. 2016, 17, 717.
Sanna C, Rosso C, Marietti M, Bugianesi E. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. International Journal of Molecular Sciences. 2016; 17(5):717.Chicago/Turabian Style
Sanna, Claudia; Rosso, Chiara; Marietti, Milena; Bugianesi, Elisabetta. 2016. "Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers." Int. J. Mol. Sci. 17, no. 5: 717.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.